Skip to main content

Table 1 Satisfaction with fertility- and sexuality-related information in 319 young breast cancer survivors

From: Satisfaction with fertility- and sexuality-related information in young women with breast cancer—ELIPPSE40 cohort

   Total Satisfied with FRI Satisfied with SRI
Continuous data Mean ± SD Mean ± SD P value Mean ± SD P value
Frequency data n (% column) n (% row)   n (% row)  
At baseline (M0)      
Age, years 36.7 ± 3.7 36.7 ± 3.7 0.658 36.7 ± 3.5 0.798
French as mother-language    0.615   0.901
No 17 (5.3) 8 (47.1)   7 (41.2)  
Yes 302 (94.7) 161 (53.3)   129 (42.7)  
Living as a couple or having regular partner    0.152   0.126
No 41 (12.9) 26 (63.4)   22 (53.7)  
Yes 278 (87.1) 143 (51.4)   114 (41.0)  
Level of education    0.977   0.086
Lower than high school graduate 103 (32.3) 54 (52.4)   53 (51.5)  
High school graduate 60 (18.8) 31 (51.7)   25 (41.7)  
Greater than high school graduate 137 (42.9) 73 (53.3)   51 (37.2)  
Missing values 19 (6.0)     
Employed    0.251   0.050
No 55 (17.2) 33 (60.0)   30 (54.5)  
Yes 264 (82.8) 136 (51.5)   106 (40.2)  
Having children    0.446   0.911
None 50 (15.7) 29 (58.0)   21 (42.0)  
One or more 259 (81.2) 135 (52.1)   111 (42.9)  
Missing values 10 (3.1)     
Place of residence    0.858   0.680
Rural 38 (11.9) 21 (55.3)   18 (47.4)  
<200,000 inhabitants 99 (31.0) 54 (54.5)   44 (44.4)  
≥200,000 inhabitants 182 (57.1) 94 (51.6)   74 (40.7)  
Had opportunity to ask questions at cancer disclosure    0.002   0.041
No 56 (17.6) 19 (33.9)   17 (30.4)  
Yes 263 (82.4) 150 (57.0)   119 (45.2)  
Received information about disease at cancer disclosure    0.124   0.006
No 89 (27.9) 41 (46.1)   27 (30.3)  
Yes 230 (72.1) 128 (55.7)   109 (47.4)  
Satisfied with information about disease at cancer disclosure    0.035   0.004
No 123 (38.6) 56 (45.5)   40 (32.5)  
Yes 196 (61.4) 113 (57.7)   96 (49.0)  
At 10 month after diagnosis (M10): medical characteristics      
Tumor stage    0.960   0.349
Stage 0 36 (11.3) 19 (52.8)   16 (44.4)  
Stage I 89 (27.9) 47 (52.8)   36 (40.4)  
Stage II 145 (45.5) 79 (54.5)   63 (43.4)  
Stage III 44 (13.8) 22 (50.0)   21 (47.7)  
Unknown 5 (1.6) 2 (40.0)   0 (0.0)  
Breast surgery    0.216   0.250
Mastectomy 121 (37.9) 59 (48.8)    57 (47.1)  
Tumorectomy 195 (61.1) 109 (55.9)    71 (40.5)  
Missing values 3 (0.9)     
Chemotherapy    0.769   0.752
No 70 (21.9) 36 (51.4)   31 (44.3)  
Yes 249 (78.1) 133 (53.4)   105 (42.2)  
FEC100 chemotherapy regimen    0.126   0.430
No 142 (44.5) 82 (57.7)   64 (45.1)  
Yes 177 (55.5) 87 (49.2)   72 (40.7)  
Radiotherapy    0.696   0.206
No 32 (10.0) 18 (56.3)   17 (53.1)  
Yes 287 (90.0) 151 (52.6)   119 (41.5)  
Trastuzumab treatment    0.728   0.185
No 259 (81.2) 136 (52.5)   115 (44.4)  
Yes 60 (18.8) 33 (55.0)   21 (35.0)  
Hormone treatment    0.197   0.094
No 120 (37.6) 58 (48.3)   44 (36.7)  
Yes 199 (62.4) 111 (55.8)   92 (46.2)  
Family history of breast or ovarian cancer    0.076   0.468
No 225 (70.5) 112 (49.8)   93 (41.3)  
Yes 94 (29.5) 57 (60.6)   43 (45.7)  
Report of “serious” comorbiditiesa by physician    0.401   0.441
No 273 (85.6) 142 (52.0)   114 (41.8)  
Yes 46 (14.4) 27 (58.7)   22 (47.8)  
At 10 month after diagnosis (M10): patient questionnaire      
Attention and⁄or memory problems    0.232   0.037
No 99 (31.0) 57 (57.6)   51 (51.5)  
Yes 201 (63.0) 101 (50.2)   78 (38.8)  
Missing values 19 (6.0)     
MAC-21 score      
Anxious preoccupation subscale 50.0 ± 10.0 48.3 ± 10.3 0.001 48.8 ± 10.4 0.084
Fighting spirit subscale 50.6 ± 10.0 51.9 ± 9.1 0.014 51.4 ± 9.0 0.196
Hopelessness/helplessness subscale 49.2 ± 9.6 48.3 ± 8.6 0.075 49.1 ± 8.6 0.784
At 48 month after diagnosis (M48)      
Preserved fertility    0.478   0.429
No 221 (69.3) 120 (54.3)   91 (41.2)  
Yes 98 (30.7) 49 (50.0)   45 (45.9)  
Satisfied with medical follow-up    0.005   0.007
No 91 (28.5) 37 (40.7)   28 (30.8)  
Yes 228 (71.5) 132 (57.9)   108 (47.4)  
Score of sexual dysfunction (RSS subscale) 9.5 ± 4.1 9.2 ± 4.2 0.113 9.1 ± 4.2 0.110
  1. FRI fertility-related information; SRI sexuality-related information; SD standard deviation; MAC-21 21-item mental adjustment scale to cancer; RSS relationship and sexuality scale
  2. aIncluding asthma, diabetes, cardiac problems, HIV infection and/or Hodgkin’s disease